Education > Webinar > Vanessa Stadlbauer-Köllner | The gut-liver axis as a novel therapeutic target in chronic liver disease

Vanessa Stadlbauer-Köllner | The gut-liver axis as a novel therapeutic target in chronic liver disease

Vanessa Stadlbauer-Köllner | The gut-liver axis as a novel therapeutic target in chronic liver disease

– Learn background information on the burden of chronic liver disease and on gut microbiome composition
– Understand the alterations in the gut-liver axis in chronic liver diseases
– Discover methods …


When
1st May 2019

This content is for verified practitioners only

Please create an account and login to view this educational resource.

Login / Register

Related Articles


Bio.Clear, Bio.Me, GI Microbiome, Immunology & Inflammation
Optimising Your Immune System

To help optimise immunity, it is imperative that we nourish the immune system from the outside-in and inside-out with an emphasis on nurturing our relationship with the microbial colonies with ...

Bio.Me, Immunology & Inflammation
Medicinal Mushroom Formula

Bio.Revive™ Mycommune is a synergistic blend of medicinal mushrooms containing over 100 biologically active compounds providing well-rounded support for immunity and biologic function.

Bio.Me
HMOs as Prebiotics to Reinforce Innate Immune System

Galactooligosaccharides (GOS) is one of our key supplements to promote a healthy microbiome for immune health and host-microbiome homeostasis.